Loading
SB
Sunho Biologics, Inc. - B Stock: price and insider trades · Hong Kong
Sunho Biologics, Inc. - B: what insiders have been doing
We have very little insider data for Sunho Biologics, Inc. - B so far: the most recent filing dates from 3 June 2024. With so few records, no pattern can be drawn yet. Every figure here comes from the filings published by HKEX and describes the past, not future prices; it is not investment advice.
Insider Decl.
2
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
n/a
n/a
Financial data
as of FY 2024FY ended December 2024 · cache
HK$6.40
Analyst consensus
Income statement
EBITDA-HK$69.6M
Net income-HK$80M0.0% margin
Valuation
P/Book1.7x
Beta0.42
Balance sheet & cash
Market capHK$1B
Total debtHK$41.2M
Free Cash Flow-HK$158.3M
Debt / Equity14%
Profitability & ownership
ROE-16.0%
ROA-9.8%
% insiders67.6%
% institutions7.4%
Last declaration on 3 June 2024
Declarations2 total
500,000 sharesShareXHKGHKEX:DA20240603E00052
100,000,000 sharesShareXHKGHKEX:DA20240603E00050
2 of 2 declarations
About Sunho Biologics, Inc. - B
Sunho Biologics, Inc. - B is a company listed on the Hong Kong Stock Exchange, specializing in the biotechnology sector. It focuses on developing innovative treatments for various diseases.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
